<DOC>
	<DOC>NCT02574988</DOC>
	<brief_summary>The multicenter registry of patients with severe cutaneous adverse reactions among tertiary medical institutes in Thailand to study clinical characteristics, etiologies, therapeutic outcomes, quality of life, and the values of in vitro drug allergy diagnosis for the confirmation of the causative drugs</brief_summary>
	<brief_title>Severe Cutaneous Adverse Reactions in Thailand</brief_title>
	<detailed_description>Patients with severe cutaneous adverse reactions (Steven-Johnson Syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms, acute generalized exanthematous pustulosis, and generalized bullous fixed drug eruption) among six tertiary medical institutes in Thailand will be recruited to study clinical characteristics, etiologies, therapeutic outcomes, quality of life, and the values of using laboratory techniques for the confirmation of the causative drugs</detailed_description>
	<mesh_term>Drug-Related Side Effects and Adverse Reactions</mesh_term>
	<mesh_term>Stevens-Johnson Syndrome</mesh_term>
	<mesh_term>Eosinophilia</mesh_term>
	<mesh_term>Drug Eruptions</mesh_term>
	<mesh_term>Acute Generalized Exanthematous Pustulosis</mesh_term>
	<mesh_term>Drug Hypersensitivity Syndrome</mesh_term>
	<criteria>Patients fulfilled criteria of probable or definite cases of SJS, TEN, DRESS, or AGEP according to RegiSCAR validation criteria as well as patients diagnosed with GBFDE Patients later confirmed to have other diagnosis than diseases mentioned above or have no sufficient data for the registry</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>drug allergy</keyword>
	<keyword>drug hypersensitivity</keyword>
	<keyword>adverse drug reactions</keyword>
	<keyword>severe cutaneous adverse reactions</keyword>
</DOC>